000 | 01943 a2200577 4500 | ||
---|---|---|---|
005 | 20250516102446.0 | ||
264 | 0 | _c20140418 | |
008 | 201404s 0 0 eng d | ||
022 | _a1460-2709 | ||
024 | 7 |
_a10.3109/13693786.2012.701765 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaliba, Faouzi | |
245 | 0 | 0 |
_aOutcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients. _h[electronic resource] |
260 |
_bMedical mycology _cFeb 2013 |
||
300 |
_a155-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmphotericin B _xadministration & dosage |
650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
650 | 0 | 4 |
_aAspergillosis _xmicrobiology |
650 | 0 | 4 |
_aCandidiasis, Invasive _xmicrobiology |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 | _aLiposomes |
650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycoses _xmicrobiology |
650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aDelvart, Valérie | |
700 | 1 | _aIchaï, Philippe | |
700 | 1 | _aKassis, Najiby | |
700 | 1 | _aBotterel, Françoise | |
700 | 1 | _aMihaila, Liliana | |
700 | 1 | _aAzoulay, Daniel | |
700 | 1 | _aAdam, René | |
700 | 1 | _aCastaing, Denis | |
700 | 1 | _aBretagne, Stéphane | |
700 | 1 | _aSamuel, Didier | |
773 | 0 |
_tMedical mycology _gvol. 51 _gno. 2 _gp. 155-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/13693786.2012.701765 _zAvailable from publisher's website |
999 |
_c21947735 _d21947735 |